Partial Laryngectomy for pT4a Laryngeal Cancer: Outcomes and Limits in Selected Cases.
OPHL
T4 laryngeal cancer
laryngeal cancer
laryngeal preservation
partial laryngectomy
radiotherapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 May 2023
22 May 2023
Historique:
received:
27
03
2023
revised:
04
05
2023
accepted:
15
05
2023
medline:
22
6
2023
pubmed:
22
6
2023
entrez:
22
6
2023
Statut:
epublish
Résumé
A large multi-institutional case series of laryngeal cancer (LC) T4a was carried out, including 134 cases treated with open partial horizontal laryngectomies (OPHL) +/- post-operative radiation therapy (PORT). The goal was to understand better whether OPHL can be included among the viable options in selected pT4a LC patients who refuse a standard approach, represented by total laryngectomy (TL) + PORT. All 134 patients underwent OPHL type I (supraglottic), II (supracricoid), or III (supratracheal), according to the European Laryngological Society Classification. Comparing clinical and pathological stages showed pT up-staging in 105 cases (78.4%) and pN up-staging in 19 patients (11.4%). Five-year data on overall survival, disease-specific survival, disease-free survival, freedom from laryngectomy, and laryngo-esophageal dysfunction-free survival (rate of patients surviving without a local recurrence or requiring total laryngectomy and without a feeding tube or a tracheostomy) were, respectively, 82.1%, 89.8%, 75.7%, 89.7%, and 78.3%. Overall, complications were observed in 22 cases (16.4%). Sequelae were observed in 28 patients (20.9%). No patients died during the postoperative period. This large series highlights the good onco-functional results of low-volume pT4a laryngeal tumors, with minimal or absent cartilage destruction, treated with OPHLs. The level of standardization of the indication for OPHL should allow consideration of OPHL as a valid therapeutic option in cases where the patient refuses total laryngectomy or non-surgical protocols with concomitant chemo-radiotherapy.
Identifiants
pubmed: 37345197
pii: cancers15102861
doi: 10.3390/cancers15102861
pmc: PMC10216219
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Laryngoscope. 2006 Oct;116(10):1907-17
pubmed: 17003702
Head Neck. 2017 Aug;39(8):1609-1620
pubmed: 28464542
J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87
pubmed: 25313184
Head Neck. 2015 Apr;37(4):557-66
pubmed: 24677483
Acta Otorhinolaryngol Ital. 2015 Jun;35(3):146-56
pubmed: 26246658
Coll Antropol. 2012 Nov;36 Suppl 2:7-12
pubmed: 23397747
Cancer. 2015 May 15;121(10):1608-19
pubmed: 25586197
Ann Otol Rhinol Laryngol. 2006 Nov;115(11):827-32
pubmed: 17165665
Head Neck. 2016 Apr;38 Suppl 1:E649-57
pubmed: 25866908
Laryngoscope. 1990 Jul;100(7):735-41
pubmed: 2362533
Eur Arch Otorhinolaryngol. 2014 Sep;271(9):2489-96
pubmed: 24691854
Head Neck. 2021 Nov;43(11):3459-3467
pubmed: 34405480
Cancers (Basel). 2020 Aug 11;12(8):
pubmed: 32796540
Eur Arch Otorhinolaryngol. 2015 Nov;272(11):3463-8
pubmed: 25359194
Int Arch Otorhinolaryngol. 2021 Jul 19;26(1):e075-e084
pubmed: 35096162
Oncologist. 2010;15 Suppl 3:25-9
pubmed: 21036886
Acta Otorhinolaryngol Ital. 2016 Oct;36(5):403-407
pubmed: 27958601
Acta Otorhinolaryngol Ital. 2019 Aug;39(4):235-243
pubmed: 31501615
Head Neck. 2018 Sep;40(9):1897-1908
pubmed: 29756363
J Clin Oncol. 2006 Aug 1;24(22):3693-704
pubmed: 16832122
Arch Otolaryngol Head Neck Surg. 2005 Jul;131(7):620-5
pubmed: 16027286
Otolaryngol Clin North Am. 2015 Aug;48(4):565-84
pubmed: 26096138
J Clin Oncol. 2015 Oct 10;33(29):3262-8
pubmed: 26351339
Medicina (Kaunas). 2021 Mar 15;57(3):
pubmed: 33804150
Head Neck. 1998 Sep;20(6):504-9
pubmed: 9702536
Head Neck. 2016 Apr;38 Suppl 1:E333-40
pubmed: 25581514
Eur Arch Otorhinolaryngol. 2021 Oct;278(10):4059-4065
pubmed: 33599842
Head Neck. 2015 Oct;37(10):1417-24
pubmed: 24839082
Arch Otolaryngol Head Neck Surg. 2002 Jul;128(7):751-8
pubmed: 12117328
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
pubmed: 17237035
Acta Otolaryngol. 2006 Jun;126(6):640-9
pubmed: 16720450
Cancers (Basel). 2019 Mar 01;11(3):
pubmed: 30832209